Revenue | ₹55.34Cr |
Net Profits | ₹4.43Cr |
Net Profit Margins | 8.01% |
Kilitch Drugs (India) Ltd’s revenue fell -4.4% since last year same period to ₹55.34Cr in the Q3 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -0.43% fall in its revenue since last 3-months.
Kilitch Drugs (India) Ltd’s net profit fell -25.67% since last year same period to ₹4.43Cr in the Q3 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -45.91% fall in its net profits since last 3-months.
Kilitch Drugs (India) Ltd’s net profit margin fell -22.25% since last year same period to 8.01% in the Q3 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -45.68% fall in its net profit margins since last 3-months.
The revenue for Kilitch Drugs (India) Ltd in the Q3 results 2025 was ₹55.34Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q3 results 2025 was ₹4.43Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q3 results 2025 was 8.01%.
The revenue for Kilitch Drugs (India) Ltd in the Q3 results 2024 was ₹57.89Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q3 results 2024 was ₹5.96Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q3 results 2024 was 10.30%.